Connor, Clark & Lunn Investment Management Ltd.

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1596800 VANCOUVER, A1

Position in AXSM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$23,913,539

+$1,130,996 QoQ

Shares Held

97,698

-27.5% QoQ

Ownership

0.187%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#73

of 494 holders

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $650,277,385 across 105 Biotechnology names. AXSM ranks #6 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	135,236	$67,175,777
2	IONS	Ionis Pharmaceuticals Inc	684,236	$54,253,072
3	ARWR	Arrowhead Pharmaceuticals, Inc.	625,569	$50,990,129
4	MIRM	Mirum Pharmaceuticals, Inc.	420,063	$49,176,775
5	REGN	Regeneron Pharmaceuticals, Inc.	42,465	$26,478,625
6	AXSM	Axsome Therapeutics, Inc. This page	97,698	$23,913,539
7	INSM	INSMED Inc	212,676	$22,675,515
8	VKTX	Viking Therapeutics, Inc.	530,607	$20,698,979

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,913,539	97,698	-27.5%	Shares	Sole	2026-08-13
2026-03-31	$22,782,543	134,792	-28.4%	Shares	Sole	2026-05-11
2025-12-31	$34,383,441	188,258	-10.0%	Shares	Sole	2026-02-10
2025-09-30	$25,391,430	209,069	-7.0%	Shares	Sole	2025-11-13
2025-06-30	$23,458,625	224,721	+27.7%	Shares	Sole	2025-08-07
2025-03-31	$20,520,115	175,942	+139.4%	Shares	Sole	2025-05-12
2024-12-31	$6,218,581	73,497	+412.6%	Shares	Sole	2025-02-10
2023-12-31	$1,141,241	14,339	+55.9%	Shares	Sole	2024-02-09
2022-03-31	$380,581	9,195	—	Shares	Sole	2022-05-12
No filing history on record for this holder in this stock.